NeuroMetrix Book Value per Share vs Market Capitalization Analysis
NURO Stock | USD 4.57 0.24 5.54% |
NeuroMetrix financial indicator trend analysis is infinitely more than just investigating NeuroMetrix recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether NeuroMetrix is a good investment. Please check the relationship between NeuroMetrix Book Value Per Share and its Market Cap accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.
Book Value Per Share vs Market Cap
Book Value per Share vs Market Capitalization Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of NeuroMetrix Book Value per Share account and Market Capitalization. At this time, the significance of the direction appears to have weak relationship.
The correlation between NeuroMetrix's Book Value per Share and Market Capitalization is 0.35. Overlapping area represents the amount of variation of Book Value per Share that can explain the historical movement of Market Capitalization in the same time period over historical financial statements of NeuroMetrix, assuming nothing else is changed. The correlation between historical values of NeuroMetrix's Book Value per Share and Market Capitalization is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Book Value per Share of NeuroMetrix are associated (or correlated) with its Market Capitalization. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Market Capitalization has no effect on the direction of Book Value per Share i.e., NeuroMetrix's Book Value per Share and Market Capitalization go up and down completely randomly.
Correlation Coefficient | 0.35 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Book Value Per Share
The ratio of equity available to common shareholders divided by the number of outstanding shares. This measure represents the value per share of a company according to its financial statements.Market Cap
Most indicators from NeuroMetrix's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into NeuroMetrix current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.As of the 23rd of April 2024, Selling General Administrative is likely to drop to about 4.7 M. In addition to that, Issuance Of Capital Stock is likely to drop to about 2.5 M
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 5.9M | 5.8M | 3.9M | 3.8M | Total Revenue | 8.3M | 8.3M | 5.9M | 5.6M |
NeuroMetrix fundamental ratios Correlations
Click cells to compare fundamentals
NeuroMetrix Account Relationship Matchups
High Positive Relationship
High Negative Relationship
NeuroMetrix fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Common Stock Shares Outstanding | 121.0K | 376.8K | 638.9K | 891.3K | 1.0M | 1.1M | |
Total Assets | 6.9M | 8.0M | 24.9M | 24.7M | 21.4M | 17.5M | |
Other Current Liab | 2.1M | 1.5M | 853.2K | 589.9K | 1.2M | 1.9M | |
Total Current Liabilities | 3.4M | 2.3M | 1.4M | 1.1M | 1.2M | 1.2M | |
Total Stockholder Equity | 2.5M | 5.2M | 23.2M | 23.4M | 20.1M | 14.4M | |
Property Plant And Equipment Net | 1.4M | 876.2K | 673.9K | 536.2K | 543.6K | 599.7K | |
Net Debt | (2.2M) | (4.8M) | (22.3M) | (3.9M) | (1.5M) | (1.6M) | |
Retained Earnings | (194.8M) | (196.9M) | (199.2M) | (203.6M) | (210.1M) | (220.6M) | |
Accounts Payable | 725.7K | 142.3K | 284.0K | 368.1K | 215.5K | 204.7K | |
Cash | 3.1M | 5.2M | 22.6M | 4.3M | 1.7M | 1.6M | |
Non Current Assets Total | 1.5M | 904.7K | 700.3K | 562.6K | 570.0K | 541.5K | |
Non Currrent Assets Other | 74.9K | 29.7K | 28.5K | 26.4K | 30.4K | 31.9K | |
Other Assets | 30.3K | 29.7K | 721.2K | 700.3K | 630.3K | 600.4K | |
Cash And Short Term Investments | 3.1M | 5.2M | 22.6M | 21.2M | 18.0M | 12.0M | |
Net Receivables | 488.0K | 334.3K | 310.8K | 646.8K | 518.8K | 492.9K | |
Common Stock Total Equity | 271.0 | 738.0 | 140.0 | 379.0 | 341.1 | 669.34 | |
Liabilities And Stockholders Equity | 6.9M | 8.0M | 24.9M | 24.7M | 21.4M | 17.5M | |
Non Current Liabilities Total | 916.7K | 461.4K | 306.7K | 207.5K | 92.5K | 87.9K | |
Inventory | 1.2M | 1.1M | 706.6K | 1.6M | 1.6M | 1.6M | |
Other Current Assets | 2.3M | 1.9M | 1.6M | 2.9M | 779.0K | 740.1K | |
Other Stockholder Equity | 197.3M | 202.1M | 222.4M | 226.9M | 230.0M | 241.5M | |
Total Liab | 4.4M | 2.7M | 1.7M | 1.3M | 1.3M | 1.3M | |
Property Plant And Equipment Gross | 1.4M | 183.5K | 2.0M | 1.2M | 1.3M | 926.1K | |
Total Current Assets | 5.4M | 7.1M | 24.2M | 24.1M | 20.9M | 15.7M | |
Accumulated Other Comprehensive Income | (1.1M) | (1.2M) | (1.2M) | 0.0 | 240.2K | 252.2K | |
Common Stock | 140.0 | 379.0 | 668.0 | 778.0 | 152.0 | 144.4 | |
Property Plant Equipment | 2.4M | 273.4K | 183.5K | 673.9K | 606.5K | 621.0K | |
Retained Earnings Total Equity | (191.3M) | (191.0M) | (194.8M) | (196.9M) | (177.2M) | (186.1M) | |
Net Tangible Assets | 6.1M | 2.5M | 5.2M | 23.2M | 26.7M | 28.0M | |
Capital Surpluse | 196.4M | 197.1M | 197.3M | 202.1M | 232.4M | 201.3M | |
Net Invested Capital | 2.5M | 5.2M | 23.2M | 23.4M | 20.1M | 13.4M | |
Net Working Capital | 2.0M | 4.8M | 22.8M | 23.0M | 19.6M | 12.9M | |
Capital Stock | 141.0 | 380.0 | 669.0 | 779.0 | 153.0 | 145.35 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards NeuroMetrix in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, NeuroMetrix's short interest history, or implied volatility extrapolated from NeuroMetrix options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeuroMetrix. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Complementary Tools for NeuroMetrix Stock analysis
When running NeuroMetrix's price analysis, check to measure NeuroMetrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroMetrix is operating at the current time. Most of NeuroMetrix's value examination focuses on studying past and present price action to predict the probability of NeuroMetrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroMetrix's price. Additionally, you may evaluate how the addition of NeuroMetrix to your portfolios can decrease your overall portfolio volatility.
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Stocks Directory Find actively traded stocks across global markets | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |
Is NeuroMetrix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.27) | Revenue Per Share 5.664 | Quarterly Revenue Growth (0.29) | Return On Assets (0.19) | Return On Equity (0.30) |
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.